| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-17 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-17 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |